{
  "num_tested_probands": [
    1,
    1,
    1,
    1
  ],
  "num_positive_het_probands": [
    0,
    3,
    0,
    0
  ],
  "positive_phenotypes": [
    [],
    [
      "extended duration of mivacurium action"
    ],
    [
      "compound heterozygous for silent mutations in BCHE"
    ],
    []
  ],
  "num_compound_or_double_hets": [
    1,
    1,
    1,
    0
  ],
  "explanation": {
    "num_tested_probands": [
      "The report discusses a single patient, a 30-year-old man, for whom genetic testing and response to mivacurium were documented.",
      "The report describes one patient and mentions analysis of genotypes in the patient's family, specifically the parents and two brothers, but relative sequencing did not detect additional characterisation beyond the compound heterozygote patient.",
      "The text primarily discusses a single patient with compound heterozygous mutations undergoing testing.",
      "The text does not explicitly state the number of probands tested, but there is mention of a genetic analysis of 'a Japanese patient,' suggesting at least one individual was tested."
    ],
    "num_positive_het_probands": [
      "There is no mention of heterozygous pathogenic variants being detected, so the number of positive HET probands is 0.",
      "Although only one proband was rigorously tested and described genetic focus, it is noted that the parents and one brother were heterozygous for a silent mutation, another brother shared the proband's compound double heterozygosity.",
      "The text does not specifically mention any probands who are heterozygous for a pathogenic variant other than being compound heterozygous.",
      "The text does not mention any probands who were heterozygous for a pathogenic variant."
    ],
    "positive_phenotypes": [
      "While the patient experienced an extensively prolonged duration of action of mivacurium, there is no clear mention of a specific phenotype attributed to a heterozygous pathogenic variant.",
      "The patient's clinical manifestation includes an 'extended duration of mivacurium action' due to compound heterozygosity.",
      "The mention of prolonged action of mivacurium in compound heterozygous patients for silent mutations in BCHE.",
      "There is no mention of specific positive proband phenotypes."
    ],
    "num_compound_or_double_hets": [
      "The patient is noted to be 'compound heterozygous for silent mutations in the butyrylcholinesterase gene,' indicating one compound heterozygote.",
      "The patient is specifically noted as compound heterozygous for two silent mutations.",
      "It is explicitly stated that the patient was compound heterozygous for two silent mutations.",
      "The document does not mention any compound or double heterozygous mutations in the probands."
    ]
  },
  "gene_symbol": [
    [
      "BCHE",
      "NES",
      "PC",
      "SI",
      "STH",
      "TAT"
    ],
    [
      "AGA",
      "AGT",
      "BCHE",
      "CAT",
      "GAA",
      "GC",
      "GCA",
      "PC",
      "SI",
      "TAT",
      "TG"
    ],
    [
      "AR",
      "BCHE",
      "CIT",
      "CRP",
      "GC",
      "NES",
      "PC",
      "SI",
      "STH",
      "TAT"
    ],
    [
      "BCHE",
      "CP",
      "NES",
      "SI",
      "STH"
    ]
  ],
  "genomic_hgvs": [
    [],
    [],
    [],
    []
  ]
}